Larry Brown, MD
Retina Specialist · Birmingham, ALNPI 1124114863
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 38.6% of the total. Among retina specialist clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$668
- Genentech USA, Inc.$638
- Novartis$256
- Alimera Sciences, Inc.$167
- Astellas Pharma US Inc$140
- plus $621 from 12 others
What the payments were for
- Food & beverage$4,053100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 96 | $1,563 |
| Regeneron Healthcare Solutions, Inc. | 17 | $668 |
| Genentech USA, Inc. | 32 | $638 |
| Novartis | 9 | $256 |
| Alimera Sciences, Inc. | 9 | $167 |
| Astellas Pharma US Inc | 1 | $140 |
| Harrow Eye, LLC | 1 | $137 |
| Alcon | 7 | $125 |
| Omeros Corporation | 1 | $57 |
| Sight Sciences, Inc. | 1 | $48 |
| Coherus Oncology, Inc. | 2 | $44 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $44 |
| ANI Pharmaceuticals, Inc. | 2 | $40 |
| Biogen | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $24 |
| Apellis Pharmaceuticals, Inc. | 1 | $23 |
| Catalyst Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,053 in reported general payments places this provider in the 90th percentile of 21 retina specialist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 111 | $6,382 |
| Brinzolamide | 15 | $2,338 |
| Prednisolone Acetate | 67 | $1,971 |
| Timolol Maleate | 133 | $943 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 48 | $626 |
| Latanoprost | 37 | $359 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Birmingham
- Jeffrey FullerBirmingham$15K
- Tyler RowseyBirmingham$1K
- Cary BaxterBirmingham$1K
- Richard FeistBirmingham$687
- Matthew OltmannsBirmingham$412
- Mathew SappBirmingham$393
- Robert MorrisBirmingham$321
- Matthew WestBirmingham$302
- Alan FranklinMobile$97K
- Alexander TalalightHuntsville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.